⌘K

Login Start Free

Home/Filings/4/0001104659-22-085788

4//SEC Filing

Dalton Lisa 4

Accession 0001104659-22-085788

CIK 0001641640other

View on SEC.gov Company Profile

Filed

Aug 2, 8:00 PM ET

Accepted

Aug 3, 9:46 PM ET

Size

4.8 KB

Accession

0001104659-22-085788

Insider Transaction Report

Form 4

Period: 2022-07-31

Nabriva Therapeutics plcNBRV

Director

Transactions

Tax Payment
Ordinary Shares
2022-07-31$0.18/sh−8,400$1,504→ 9,100 total

Footnotes (1)

[F1]These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.

Documents

1 file

4
tm2222534-3_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Nabriva Therapeutics plc

CIK 0001641640

Entity typeother

Related Parties

1

filerCIK 0001732196

Filing Metadata

Form type: 4
Filed: Aug 2, 8:00 PM ET
Accepted: Aug 3, 9:46 PM ET
Size: 4.8 KB

View on SEC.gov